INSIGHTS ON DRUG DEVELOPMENT

• Assessment Of Compound Toxicity Effects With High-Content Imaging

  3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.

• 3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems

  Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.

• The Art And Science Of Topical Formulations

  Chief Scientific Officer Jon Lenn discusses the balance of art and science in topical formulation development, emphasizing advanced skin models for optimized delivery, activity, and product stability.

• Quantification Of Semaglutide With A Reliable Analytical Method

  Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.

• Optimizing Pediatric Product Development For Commercialization Success

  4/10/2024

  Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Explore various dosing solutions and learn how to streamline your pediatric development journey.

• Process Intensification: Your Guide To "Doing More With Less"

  8/5/2025

  Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.

• Developing High Concentration Biopharmaceuticals: Formulation Considerations

  9/11/2024

  This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.

• In Vivo Testing Of Nasal Dosage Forms

  5/7/2025

  Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.

• Accelerate Your pDNA And mRNA Process Development

  11/13/2025

  Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.